|
NCI CANCERLIT® Search: Neuroblastoma - October 2001
[New prognostic factors of neuroblastoma] [Value of 123I-MIBG scanning, neuron-specific enolase and serum ferritin in the diagnosis and follow-up of patients with neuroblastoma] Esthesioneuroblastoma: the impact of treatment modality. The... |
|
|
NCI CANCERLIT® Search: Neuroblastoma - September 2001
Table of ContentsComparative genomic hybridization reveals changes in DNA-copy number in poor-risk neuroblastoma.Analysis of PTEN/MMAC1 alteration in neuroblastoma.Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent... |
|
|
NCI CANCERLIT® Search: Neuroblastoma - April 2002
Cervical neuroblastoma, stage IV-S. Substitute "prostate cancer" for "neuroblastoma"? Marginal decrease in mortality and marked increase in incidence as a result of neuroblastoma screening at 6 months of age: cohort study in Aluminum affects... |
|
|
NCI CANCERLIT® Search: Neuroblastoma - August 2002
[Modulation of voltage-gated sodium channels by recombinant interferon-alpha2b in the human neuroblastoma cell line IMR-32] Complicated mechanisms of class II transactivator transcription deficiency in small cell lung cancer and... |
|
|
NCI CANCERLIT® Search: Neuroblastoma - February 2002
Surgical treatment for abdominal neuroblastoma in the laparoscopic era. Esterase inhibition in SH-SY5Y human neuroblastoma cells following exposure to organophosphorus compounds for 28 days. RB2/p130 ectopic gene expression in neuroblastoma... |
|
|
NCI CANCERLIT® Search: Neuroblastoma - January 2002
Late detection of neuroblastoma in a patient with prolonged cerebellar ataxia without opsoclonus. Olfactory neuroblastoma--an unusual presentation. Thallium-201 scintigraphy of neuroblastoma: different results for primary tumors and... |
|
|
NCI CANCERLIT® Search: Neuroblastoma - July 2002
Activation of vascular endothelial growth factor A transcription in tumorigenic glioblastoma cell lines by an enhancer with cell Primary neuroblastoma of the maxillary sinus. Oxidative stress modulates tyrosine kinase receptor A and p75... |
|
|
NCI CANCERLIT® Search: Neuroblastoma - June 2002
Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line. Buthionine sulfoximine and myeloablative concentrations of melphalan overcome resistance in a melphalan-resistant... |
|
|
NCI CANCERLIT® Search: Neuroblastoma - March 2002
Cancer metastatic to the orbit: the 2000 Robert M. Curts Lecture. Glutathione transferase P1 polymorphism in neuroblastoma studied by endonuclease restriction mapping. Oral etoposide following combination chemotherapy and radiation therapy ... |
|
|
NCI CANCERLIT® Search: Neuroblastoma - May 2002
Congenital neuroblastoma with cutaneous metastases. Upregulation of vascular endothelial growth factor receptors is associated with advanced neuroblastoma. P53 mediates ceramide-induced apoptosis in SKN-SH cells. The N-myc and c-myc downstream... |
|
|
NCI CANCERLIT® Search: Neuroblastoma - October 2002
Pepper syndrome, truncus arteriosus communis and abnormal pulmonary venous return: an unusual association. Localization of the 17q breakpoint of a constitutional 1;17 translocation in a patient with neuroblastoma within a 25-kb segment ... |
|
|
NCI CANCERLIT® Search: Neuroblastoma - September 2002
Dioctanoylglycerol stimulates accumulation of [methyl-14C]choline and its incorporation into acetylcholine and phosphatidylcholine in a human [Biochemical diagnosis of pheochromocytoma and neuroblastomas] Characteristics and outcome of... |
|
|
NCI/PDQ® Health professionals: Neuroblastoma Screening (PDQ®)
TABLE OF CONTENTS Summary of EvidenceInterventionBenefitsHarmsSignificanceIncidence and MortalityScreening Method and SensitivityEvidence of BenefitChanges to This Summary (07/23/2010)Questions or Comments About This SummaryAbout This PDQ®... |
|
|
NCI/PDQ® Health professionals: Neuroblastoma Treatment (PDQ®)
TABLE OF CONTENTS General InformationPredisposition to NeuroblastomaPresentation of NeuroblastomaOpsoclonus/myoclonus syndromeDiagnosisPrognosisAgeBiologic factorsUnique Aspects of NeuroblastomaBiologically discrete types of... |
|
|
NCI/PDQ® Pacientes: Neuroblastoma: Tratamiento (PDQ®)
TABLE OF CONTENTS Información general sobre el neuroblastomaEstadios del neuroblastomaNeuroblastoma evolutivo o recidivanteAspectos generales de las opciones de tratamientoOpciones de tratamiento del neuroblastoma Neuroblastoma de riesgo... |
|
|
NCI/PDQ® Patients: Neuroblastoma Screening (PDQ®)
TABLE OF CONTENTS What is screening?General Information About Neuroblastoma CancerNeuroblastoma ScreeningRisks of Neuroblastoma ScreeningChanges to This Summary (06/08/2009)Questions or Comments About This SummaryGet More Information From NCIAbout... |
|
|
NCI/PDQ® Patients: Neuroblastoma Screening (PDQ®)
TABLE OF CONTENTS What is screening?General Information About Neuroblastoma CancerNeuroblastoma ScreeningRisks of Neuroblastoma ScreeningChanges to This Summary (06/08/2009)Questions or Comments About This SummaryGet More Information From NCIAbout... |
|
|
NCI/PDQ® Patients: Neuroblastoma Treatment (PDQ®)
TABLE OF CONTENTS General Information About NeuroblastomaStages of NeuroblastomaProgressive/Recurrent NeuroblastomaTreatment Option OverviewTreatment Options for NeuroblastomaLow-Risk Neuroblastoma Intermediate-Risk NeuroblastomaHigh-Risk... |
|
|
NCI/PDQ® Profesionales De Salud: Neuroblastoma: Tratamiento (PDQ®)
TABLE OF CONTENTS Información generalPredisposición al neuroblastomaPresentación del neuroblastomaSíndrome opsoclono-mioclonoDiagnósticoPronósticoEdadFactores biológicosAspectos singulares del neuroblastomaTipos de... |